Nordea Investment Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.72M Buy
58,660
+28
+0% +$3.21K 0.01% 501
2025
Q1
$6.17M Buy
58,632
+60
+0.1% +$6.31K 0.01% 496
2024
Q4
$6.25M Buy
58,572
+2,970
+5% +$317K 0.01% 500
2024
Q3
$5.48M Sell
55,602
-3,097
-5% -$305K 0.01% 516
2024
Q2
$4.87M Sell
58,699
-9,629
-14% -$799K 0.01% 533
2024
Q1
$4.94M Sell
68,328
-643
-0.9% -$46.4K 0.01% 539
2023
Q4
$4.93M Sell
68,971
-2,381
-3% -$170K 0.01% 524
2023
Q3
$4.39M Sell
71,352
-796
-1% -$49K 0.01% 530
2023
Q2
$5.27M Buy
72,148
+505
+0.7% +$36.9K 0.01% 507
2023
Q1
$5.18M Sell
71,643
-2,230
-3% -$161K 0.01% 513
2022
Q4
$4.88M Sell
73,873
-38,241
-34% -$2.52M 0.01% 527
2022
Q3
$6.1M Sell
112,114
-377
-0.3% -$20.5K 0.01% 468
2022
Q2
$6.09M Sell
112,491
-3,475
-3% -$188K 0.01% 482
2022
Q1
$8.46M Buy
115,966
+1,454
+1% +$106K 0.01% 456
2021
Q4
$11.2M Sell
114,512
-851
-0.7% -$83K 0.01% 386
2021
Q3
$10.1M Sell
115,363
-1,759
-2% -$154K 0.01% 401
2021
Q2
$9.59M Buy
117,122
+13,074
+13% +$1.07M 0.01% 408
2021
Q1
$9.96M Sell
104,048
-2,037
-2% -$195K 0.01% 379
2020
Q4
$6.58M Buy
106,085
+39,503
+59% +$2.45M 0.01% 448
2020
Q3
$4.07M Sell
66,582
-65,714
-50% -$4.02M 0.01% 547
2020
Q2
$9.42M Buy
132,296
+66,443
+101% +$4.73M 0.01% 468
2020
Q1
$3.03M Buy
65,853
+2,664
+4% +$123K 0.01% 567
2019
Q4
$4.14M Buy
63,189
+1,663
+3% +$109K 0.01% 605
2019
Q3
$3.84M Buy
61,526
+20,270
+49% +$1.26M 0.01% 611
2019
Q2
$2.94M Buy
41,256
+12,808
+45% +$912K 0.01% 674
2019
Q1
$2.23M Sell
28,448
-1,267
-4% -$99.4K ﹤0.01% 848
2018
Q4
$2.52M Sell
29,715
-102
-0.3% -$8.64K 0.01% 787
2018
Q3
$5.11M Buy
29,817
+4,228
+17% +$724K 0.01% 546
2018
Q2
$3.31M Sell
25,589
-6,423
-20% -$830K 0.01% 584
2018
Q1
$3.3M Buy
32,012
+2,756
+9% +$284K 0.01% 538
2017
Q4
$2.5M Buy
29,256
+1,606
+6% +$137K 0.01% 591
2017
Q3
$2.35M Buy
27,650
+784
+3% +$66.6K 0.01% 586
2017
Q2
$2.04M Buy
26,866
+3,361
+14% +$255K 0.01% 576
2017
Q1
$1.55M Buy
23,505
+5,346
+29% +$353K ﹤0.01% 662
2016
Q4
$1.15M Buy
18,159
+1,244
+7% +$78.9K ﹤0.01% 712
2016
Q3
$1.08M Buy
16,915
+8,672
+105% +$552K ﹤0.01% 708
2016
Q2
$613K Buy
+8,243
New +$613K ﹤0.01% 691